Mammography Plus Automated Breast Ultrasound (Abus) Results In Improved Earlier Detection Of Breast Cancer: A Case Study By Ge Healthcare


While mammography remains the gold standard for detecting breast cancer, research has shown it is not equally effective in all women.1 In the 40% of U.S. women with dense breast tissue, mammography can miss up to one third of breast cancers.2 This may lead to a delay in diagnosis and a worse prognosis for women with dense breast tissue.

Mammography has been shown to miss 30% of cancer in dense breasts.3 Using screening ultrasound for woman with dense breasts is helping address this challenge. However, the limitations of traditional hand-held ultrasound (HHUS), which include operator dependency, variability and long acquisition times, make it inefficient for broad-scale breast cancer screening. With the introduction of ABUS (automated breast ultrasound), clinicians are able to address these variables and shorten both exam and read times, while increasing sensitivity with a multi-modality approach.

Clinical research studies demonstrate that when used as an adjunct to mammography, ABUS can detect small, invasive, node-negative cancers. The ability to find mammographically occult cancers at smaller sizes may translate into reduced mortality and lower morbidity for patients – while also creating the potential to reduce therapy costs. The following cases demonstrate the clinical value of using ABUS as an adjunct screening for women with dense breast tissue.

Download '.pdf' Format of the Case Study.

Download Casestudies